Aarti Drugs reports strong Q3 FY26 performance, PAT surges 58% YoY
FDA reviews AstraZeneca’s Saphnelo for subcutaneous use in Lupus
AstraZeneca & Daiichi Sankyo gain priority review for Datroway in hard-to-treat breast cancer
Novo Medi Sciences launches ‘G.A.U.R.I.’ to drive immunization for underprivileged girls
AbbVie posts higher revenue in 2025, led by immunology & neuroscience growth
Novo Nordisk weathers pricing pressure, bets big on oral Wegovy
Strides Pharma Inc receives USFDA closure report for Chestnut Ridge formulations facility
Lupin launches Topiramate ER capsules in US
Zydus receives FDA’s tentative approval for Dapagliflozin Tablets
Revvity posts higher Q4 earnings, lifts 2026 outlook as diagnostics strength offsets margin pressure
US revenue increased 43% to $12.9 billion, fueled by a 50% jump in volume, partially offset by a 7% decline in realized prices
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
